Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion type Assertion NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_head.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion wasGeneratedBy ECO_0000203 NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_provenance.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion wasDerivedFrom befree-20140225 NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_provenance.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion SIO_000772 21514686 NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_provenance.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion evidence source_evidence_literature NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_provenance.
- NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_assertion description "[The results showed that variant genotypes of CCL2 rs3760396 and CCL8 rs3138035 were associated with a significantly decreased risk of death for NSCLC (dominant model: adjusted HR=0.65, 95% CI=0.48-0.89 for rs3760396; dominant model: adjusted HR=0.65, 95% CI=0.49-0.86 for rs3138035), while CXCL12 rs1804429 was associated with an increased risk of death for NSCLC (CC vs AA: adjusted HR=6.03, 95% CI=1.44-25.24).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501049.RAA6bfZR_GF2NaaIdXHXKMRpx8xTB_oinXCxGaz76FffM130_provenance.